Novel Cardiovascular Risk Factor Prediction of Cardiovascular Events in the (Type 2 Diabetes) FIELD Study and Effects of Fenofibrate

被引：0
|
作者：
Keech, Anthony C.
Alicia, Jenkins
Whiting, Malcolm
Barter, Philip
Sullivan, David R.
Donoghoe, Mark
Januszewski, Andrej
Karschimkus, Connie
Blankenberg, Stefan
Simes, John
Scott, Russell
Laakso, Markku
Taskinen, Marja-Riitta
Best, James D.
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Johannes Gutenberg Univ Mainz, Mainz, Germany
[6] Christchurch Hosp, Christchurch, New Zealand
[7] Univ Kuopio, FIN-70211 Kuopio, Finland
[8] Helsinki Univ Hosp, Helsinki, Finland
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Biomarkers; Risk factors; Cardiovascular disease; Type; 2; Diabetes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18865
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study
    Fangel, Mia Vicki
    Nielsen, Peter Bronnum
    Kristensen, Jette Kolding
    Larsen, Torben Bjerregaard
    Overvad, Thure Filskov
    Lip, Gregory Y. H.
    Jensen, Martin Bach
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (06) : E269 - E279
  • [32] Type 2 diabetes, thiazolidinediones, and cardiovascular risk
    Taylor, Clare
    Hobbs, F. D. Richard
    BRITISH JOURNAL OF GENERAL PRACTICE, 2009, 59 (564) : 520 - 524
  • [33] Cardiovascular risk in patients with type 2 diabetes: A systematic review of prediction models
    Galbete, Arkaitz
    Tamayo, Ibai
    Librero, Julian
    Enguita-German, Monica
    Cambra, Koldo
    Ibanez-Beroiz, Berta
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 184
  • [34] Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
    van Dieren, Susan
    Kengne, Andre P.
    Chalmers, John
    Beulens, Joline W. J.
    Cooper, Mark E.
    Grobbee, Diederick E.
    Harrap, Stephen
    Mancia, Giuseppe
    Neal, Bruce
    Patel, Anushka
    Poulter, Neil
    van der Schouw, Yvonne T.
    Woodward, Mark
    Zoungas, Sophia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (01) : 83 - 90
  • [35] Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study
    Spijkerman, AMW
    Dekker, JM
    Nijpels, G
    Jager, A
    Kostense, PJ
    van Hinsbergh, VWM
    Bouter, LM
    Heine, RJ
    Stehouwer, CDA
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (12) : 924 - 930
  • [36] Trials of cardiovascular risk factor management in type 2 diabetes
    Patel, Anushka
    Joshi, Rohina
    de Galan, Bastiaan
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) : 288 - 294
  • [37] Update on Type 2 Diabetes as a Cardiovascular Disease Risk Equivalent
    Kuusisto, Johanna
    Laakso, Markku
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (02)
  • [38] CARDIOVASCULAR RISK-FACTORS IN TYPE-2 DIABETES
    LESOBRE, B
    DIABETES & METABOLISM, 1994, 20 (3BIS) : 351 - 356
  • [39] The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
    Caussy, Cyrielle
    Aubin, Adrien
    Loomba, Rohit
    CURRENT DIABETES REPORTS, 2021, 21 (05)
  • [40] Joint effects of physical frailty and traditional cardiovascular risk factor control on cardiovascular disease in patients with diabetes
    Li, Jie
    Li, Jiang
    Yu, Yuefeng
    Sun, Ying
    Yu, Bowei
    Shen, Wenqi
    Cai, Lingli
    Wang, Ningjian
    Wang, Bin
    Lu, Yingli
    JOURNAL OF NUTRITION HEALTH & AGING, 2024, 28 (10)
12345